a.vestergaard
TL2 · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 16 June 2025 · last posted 4h
84Posts here
1Topics
2Solutions
1.5kLikes received
1.7kLikes given
21Badges
208Days visited
4.4kPosts read
Recent activity
Full stream-
How to ask a question when you cannot say why you are asking it Replied, post #54 · Start Here › How to Ask · 28 Jul 2026 · 2 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Seven-day rolling means and why weekly readings mislead Replied, post #120 · Outcomes › Progress reports · 27 Jul 2026 · 0 likes I have three months of notes on seven-day rolling and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Prescription portability between countries Replied, post #111 · Access › International · 25 Jul 2026 · 1 like Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
-
What steady state means for the decision to escalate Replied, post #31 · Practice › Dosing & titration · 18 Jul 2026 · 0 likes Adding the boring version of steady state, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #71 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes Post #67 and I disagree about the size of the effect, not about the direction. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #71 · Practice › Administration · 15 Jul 2026 · 15 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.
-
CJC-1295 with and without DAC: what the modification does Replied, post #112 · Compounds › Secretagogues & GH axis · 15 Jul 2026 · 3 likes The thing about CJC-1295 that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #115 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #3 · Compounds › Other compounds · 23 Jun 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #13 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes On consumer-accessible tests the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Journal club: what we got wrong in an earlier session Replied, post #14 · Evidence › Journal club · 19 Jun 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Old habit: I…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #74 · Safety › Contraindications · 15 Jun 2026 · 15 likes Confirming post #72 from a second method, which matters more than confirming it from a second person. Somebody's condition being on a list does not settle the decision,…